4//SEC Filing
Martin James Joseph 4
Accession 0001493152-21-017327
CIK 0001412486other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:06 PM ET
Size
6.0 KB
Accession
0001493152-21-017327
Insider Transaction Report
Form 4
Martin James Joseph
Co-CEO and CFO
Transactions
- Award
Stock Options (Right to Buy)
2021-07-16+250,000→ 250,000 totalExercise: $1.11Exp: 2031-07-16→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]The stock options were issued pursuant to the 2015 Equity Incentive Plan and are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code (the "Code").
- [F2]The stock options vest and become exercisable as follows, subject in each case to the limitations on exercisability of incentive stock options under Section 422 of the Code: one-half will vest on July 16, 2022 and the remaining half will vest in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to continued employment on each applicable vesting date.
Documents
Issuer
Cocrystal Pharma, Inc.
CIK 0001412486
Entity typeother
Related Parties
1- filerCIK 0001510224
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:06 PM ET
- Size
- 6.0 KB